Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: WOW 50 cents

Getting to the NASDAQ isn't the problem. How much dilution it'll take to get there is. Not much point in averaging down, even now, let alone after any kind of reverse split necessary for NASDAQ acceptance. The only other possibility is news of a promising research breakthrough. And, really, how likely is that?

Share
New Message
Please login to post a reply